Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samra Turajlic

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
STAR Protocols|July 5, 2021
A protocol for representative sampling of solid tumors to improve the accuracy of sequencing resultsLisa L Gallegos, Ashley Gilchrist, Lavinia Spain, et al.
Cancer Discovery|July 18, 2013
SF3B1 mutations are associated with alternative splicing in uveal melanomaSimon J Furney, Malin Pedersen, David Gentien, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitisJames L Alexander, Hajir Ibraheim, Camellia Richards, et al.
Cancer Discovery|December 18, 2012
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Cancer Discovery|February 6, 2026
Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in MelanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Science Signaling|March 27, 2014
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signalingBerta Sanchez-Laorden, Amaya Viros, Maria Romina Girotti, et al.
Journal for Immunotherapy of Cancer|April 5, 2024
Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitisCathrin L C Gudd, Eoin Mitchell, Stephen R Atkinson, et al.
Research Square|December 18, 2023
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Houlston, Richard Culliford, Sam Lawrence, et al.
European Urology|October 6, 2022
Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82Mark A Rubin, Mahul B Amin, Eva Compérat, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 16, 2019
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitorsAine O'Reilly, Peta Hughes, Jasmine Mann, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
STAR Protocols|July 5, 2021
A protocol for representative sampling of solid tumors to improve the accuracy of sequencing resultsLisa L Gallegos, Ashley Gilchrist, Lavinia Spain, et al.
Cancer Discovery|July 18, 2013
SF3B1 mutations are associated with alternative splicing in uveal melanomaSimon J Furney, Malin Pedersen, David Gentien, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitisJames L Alexander, Hajir Ibraheim, Camellia Richards, et al.
Cancer Discovery|December 18, 2012
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Cancer Discovery|February 6, 2026
Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in MelanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Science Signaling|March 27, 2014
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signalingBerta Sanchez-Laorden, Amaya Viros, Maria Romina Girotti, et al.
Journal for Immunotherapy of Cancer|April 5, 2024
Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitisCathrin L C Gudd, Eoin Mitchell, Stephen R Atkinson, et al.
Research Square|December 18, 2023
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Houlston, Richard Culliford, Sam Lawrence, et al.
European Urology|October 6, 2022
Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82Mark A Rubin, Mahul B Amin, Eva Compérat, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 16, 2019
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitorsAine O'Reilly, Peta Hughes, Jasmine Mann, et al.
Pageof 13